Gut-Lung Axis: The Microbial Contributions and Clinical Implications
The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Abstract
Gut microbiota interacts with host immune system in ways that influence the development of disease. Advances in respiratory immune system also broaden our knowledge of the interaction between host and microbiome in the lung. Increasing evidence indicated the intimate relationship between the gastrointestinal tract and respiratory tract. Exacerbations of chronic gut and lung disease have been shown to share key conceptual features with the disorder and dysregulation of the microbial ecosystem. In this review, we discuss the impact of gut and lung microbiota on disease exacerbation and progression, and the recent understanding of the immunological link between the gut and the lung, the gut-lung axis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the gut-lung axis is the primary cross-talk for this communication.”
From The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy (2021) · doi:10.3389/fonc.2021.720842 · cites this paper as [22]
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“Microbiota influences the host immune homeostasis The catalog of non-redundant human intestinal microbial genes contains 3.3 million microbial genes, 150-fold more than the human gene (Qin et al., 2010).”
BackgroundInfluentialSelf-citationVagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211 · cited 1×
“However, in studies of endotoxemia, vagus nerve stimulation (VNS) has been shown to decrease the systemic inflammatory response syndrome (SIRS) by attenuating the systemic inflammatory response to endotoxin (Borovikova et al., 2000).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Commensal species have evolved mechanisms to suppress unwanted inflammation by inducing immune tolerance through the interaction with the innate immune system or modulating the adaptive immune system (Hooper et al., 2012; Lee & Mazmanian, 2010).”
BackgroundThe impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 1×
“Dysbiosis of the gut microbiota plays a pivotal role in the pathogenesis of chronic bowel diseases, such as chronic inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC) (Clemente et al., 2012; McLean et al., 2015; Nishio & Honda, 2012).”
BackgroundDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“However, recent studies have proven that fecal microbiota transplant is significantly more effective in the treatment of recurrent Clostridium difficile infection by increasing fecal bacterial diversity than standard antibiotic therapy (Shimizu et al., 2013; van Nood et al., 2013).”
BackgroundTreg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“Obviously, the frequency of Foxp3þ Treg cells in the gut lamina propria is notably higher (>30% within CD4þ T cell) than in other organs (Atarashi et al., 2013; Nagano et al., 2012).”
BackgroundCell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178 · cited 1×
“Using the model of hemorrhagic shock, germ-free mice have improved survival compared to animals with an intact microflora, which is associated with an abrogation of the systemic inflammatory response (Fox et al., 2012; Kalogeris et al., 2012).”
BackgroundThe Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050 · cited 1×
“In addition, gram positive bacteria can translocate through impaired intestinal mucus layer and promote the generation of immune cells such as T helper 17 (Th17) cells and memory Th1 immune responses (Atarashi et al., 2011; Viaud et al., 2013).”
BackgroundTGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 1×
“Furthermore, they specified that there was increased representation of Proteobacteria in COPD airways, which was accompanied by a reduction of Bacteriodetes (Hilty et al., 2010).”
Background
Research works printed but not linked: 4
- Alkhawaja S, 2015, Cochrane Database Syst Rev, 8, CD008875
- Pammi M, 2015, Cochrane Database Syst Rev, 2, CD007137
- Teo E, 2014, Cochrane Database Syst Rev, 9, CD010010
- Wohlauer MV, 2011, J Surg Res, 170, 314
Cited by
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
“The effect is called the “gut-lung axis” (20,21), which may further explain why patients with COVID-19 pneumonia often have digestive symptoms.”
Self-citationThe Role of Lung and Gut Microbiota in the Pathology of Asthma
Barcik, W., Boutin, R. C. T., Sokolowska, M., & Finlay, B. B. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.007 · Cited by 613
The influence of the microbiome on respiratory health
Wypych, T. P., Wickramasinghe, L. C., & Marsland, B. J. (2019) · Nature Immunology · doi:10.1038/s41590-019-0451-9 · Cited by 611
Wiertsema, S. P., van Bergenhenegouwen, J., Garssen, J., & Knippels, L. M. J. (2021) · Nutrients · doi:10.3390/nu13030886 · Cited by 512
“Another mechanism through which events in the gut can impact disease in the lung is through the common mucosal immune system, in which antigen-specific B cells primed in the gut can migrate to a distal effective site via a thoracic duct [57].”
BackgroundTang, J., Xu, L., Zeng, Y., & Gong, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107272 · Cited by 498
Metadata
- Authors
- He, Y., Wen, Q., Yao, F., Xu, D., Huang, Y., & Wang, J.
- Affiliations
- Wuhan Union Hospital (CN)
- Tongji Hospital (CN)
- Corresponding author
- Huang, Yuancheng
- Wang, Junshuai
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2016-10-26
- Volume
- 43
- Issue
- 1
- Pages
- 81-95
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W2546037380
- Cited by
- 301
- References
- 179
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 38 · 2023: 31 · 2022: 40 · 2021: 48 · 2020: 43 · 2019: 14 · 2018: 14 · 2017: 8
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- gut-lung axis, gut microbiota, lung microbiome, host-microbe interactions, disease exacerbation, chronic lung disease, gastrointestinal diseases, dysbiosis, clinical implications
- MeSH terms
- Animals, Gastrointestinal Diseases, Humans, Lung, Lung Diseases, Gastrointestinal Tract, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut-Lung Axis: The Microbial Contributions and Clinical Implications. https://app.cochat.ai/papers/10.1080/1040841x.2016.1176988
- The paper
- He, Y., Wen, Q., Yao, F., Xu, D., Huang, Y., & Wang, J. (2017). Gut-Lung Axis: The Microbial Contributions and Clinical Implications. Critical Reviews in Microbiology. https://doi.org/10.1080/1040841x.2016.1176988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.